Skip links

Blog

the-hidden-identity-of-leukemia

The hidden identity of leukemia

Researchers from Tokyo Medical and Dental University (TMDU) use various technologies to better characterize a rare form of leukemia on the molecular level Credit: Department of Pediatrics and Developmental Biology, TMDU Researchers from Tokyo Medical and Dental University (TMDU) use various technologies to better characterize
leukaemia:-artificial-intelligence-provides-support-in-diagnostics

Leukaemia: Artificial intelligence provides support in diagnostics

Decisions on treatment for patients with acute myeloid leukemia (AML) – a highly aggressive form of leukemia – are based, among other things, on a series of certain genetic features of the disease; but at the time when a diagnosis is made, this information is not available.
epigenetic-therapy-shows-promise-for-endocrine-resistant-breast-cancer

Epigenetic therapy shows promise for endocrine-resistant breast cancer

Endocrine resistance – a major cause of breast cancer deaths – can be underpinned by an epigenetic change called DNA methylation, researchers at the Garvan Institute of Medical Research have discovered. The team successfully reversed this methylation to reduce cancer growth in patient-derived animal models.
researchers-identify-why-cancer-immunotherapy-can-cause-colitis

Researchers identify why cancer immunotherapy can cause colitis

Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment. Credit: Michigan Medicine Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems
inhalable-sensors-could-enable-early-lung-cancer-detection

Inhalable sensors could enable early lung cancer detection

CAMBRIDGE, MA — Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present. Credit: MIT researchers CAMBRIDGE, MA — Using a new technology developed
minimizing-immunotherapy’s-potentially-harmful-side-effects

Minimizing immunotherapy’s potentially harmful side effects

MIAMI, FLORIDA (EMBARGOED UNTIL JAN. 4, 2024, at 10 AM EST) – Recent advances in treating multiple myeloma, the second most common blood cancer, and other blood malignancies are providing improved outcomes – and hope – to patients worldwide. Credit: Photo by Sylvester MIAMI, FLORIDA
Explore
Drag